Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7NXM

Structure of human cathepsin K in complex with the selective activity-based probe Gu3416

Summary for 7NXM
Entry DOI10.2210/pdb7nxm/pdb
DescriptorCathepsin K, SULFATE ION, N-(4-(dibenzylamino)-4-oxobutyl)-2-(5-(dimethylamino)pentanamido)-4-methylpentanamide, ... (4 entities in total)
Functional Keywordshydrolase, inhibitor, complex, activity-based probe, acrylamide inhibitor
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight24299.46
Authors
Busa, M.,Benysek, J.,Lemke, C.,Gutschow, M.,Mares, M. (deposition date: 2021-03-18, release date: 2021-09-08, Last modification date: 2024-11-20)
Primary citationLemke, C.,Benysek, J.,Brajtenbach, D.,Breuer, C.,Jilkova, A.,Horn, M.,Busa, M.,Ulrychova, L.,Illies, A.,Kubatzky, K.F.,Bartz, U.,Mares, M.,Gutschow, M.
An Activity-Based Probe for Cathepsin K Imaging with Excellent Potency and Selectivity.
J.Med.Chem., 64:13793-13806, 2021
Cited by
PubMed Abstract: The cysteine protease cathepsin K is a target for the treatment of diseases associated with high bone turnover. Cathepsin K is mainly expressed in osteoclasts and responsible for the destruction of the proteinaceous components of the bone matrix. We designed various fluorescent activity-based probes (ABPs) and their precursors that bind to and inactivate cathepsin K. ABP exhibited extraordinary potency (/ = 35,300 Ms) and selectivity for human cathepsin K. Crystal structures of cathepsin K in complex with ABP and its nonfluorescent precursor were determined to characterize the binding mode of this new type of acrylamide-based Michael acceptor with the particular orientation of the dibenzylamine moiety to the primed subsite region. The cyanine-5 containing probe allowed for sensitive detection of cathepsin K, selective visualization in complex proteomes, and live cell imaging of a human osteosarcoma cell line, underlining its applicability in a pathophysiological environment.
PubMed: 34473502
DOI: 10.1021/acs.jmedchem.1c01178
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.72 Å)
Structure validation

229183

PDB entries from 2024-12-18

PDB statisticsPDBj update infoContact PDBjnumon